Nurix Therapeutics Inc
NRIX
$25.44-0.24%
End of day · as of Sep 21, 2026, 1:01 AM ET
Mkt cap
$1.77B
EV/Sales
18.1
P/E ratio
N/A
FY2025 Revenue
$83.98M
EPS (TTM)
$-3.46
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-314.90%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Latest reported NRIX revenue for 2025-11-30 was $84.0M. Net income was -$264.5M. Revenue was up 54.0% from 2024-11-30 to 2025-11-30. NRIX currently screens at market cap $1.77B.
Use this NRIX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full NRIX income, balance, and cash tables.
Nurix Therapeutics Inc (NRIX) is a biotechnology company in the Healthcare sector.
Latest cached Nurix Therapeutics Inc (NRIX) revenue for Nov 30, 2025 was $84.0M. Net income was -$264.5M. Statements: https://lician.com/financials/nrix
Nurix Therapeutics Inc (NRIX) market capitalization is $1.77B on the latest cached snapshot.
Nurix Therapeutics Inc (NRIX) cached previous close $25.50; day range $25.01 – $25.80; volume 2,735,501. Session quote: https://lician.com/quote/nrix
Nurix Therapeutics Inc (NRIX) latest cached earnings event is "NRIX earnings" on Oct 8, 2026. Earnings calendar: https://lician.com/earnings
The latest cached NRIX filing is 8-K · Oct 13, 2026. Filings: https://lician.com/sec/nrix